Inventor · disambiguated record
Kanneboyina Nagaraju
Also filed as: NAGARAJU KANNEBOYINA
12 granted patents·5 pending applications·81 citations·filing 2009–2025
92Inventor score
Top patents by PatentIndex Score
17 records- 0193US10799514B2Non-hormonal steroid modulators of NF-kappa beta for treatment of diseaseREVERAGEN BIOPHARMA INC·Filed 2016·Granted Oct 13, 2020·6 cites·18 claims
- 0292US10857161B2Non-hormonal steroid modulators of NF-kB for treatment of diseaseREVERAGEN BIOPHARMA INC·Filed 2018·Granted Dec 8, 2020·6 cites·21 claims
- 0392US10206933B2Non-hormonal steroid modulators of NF-kB for treatment of diseaseREVERAGEN BIOPHARMA INC·Filed 2017·Granted Feb 19, 2019·7 cites·14 claims
- 0492US9649320B2Non-hormonal steroid modulators of NF-κB for treatment of diseaseREVERAGEN BIOPHARMA INC·Filed 2016·Granted May 16, 2017·8 cites·3 claims
- 0592US8207151B2Non-hormonal steroid modulators of NF-κB for treatment of diseaseMCCALL JOHN M·Filed 2009·Granted Jun 26, 2012·13 cites·2 claims
- 0691US8334279B2Non-hormonal steroid modulators of NF-κB for treatment of diseaseMCCALL JOHN M·Filed 2011·Granted Dec 18, 2012·10 cites·11 claims
- 0790US9434758B2Non-hormonal steroid modulators of NF-κB for treatment of diseaseREVERAGEN BIOPHARMA INC·Filed 2014·Granted Sep 6, 2016·8 cites·2 claims
- 0889US9198921B2Non-hormonal steroid modulators of NF-κB for treatment of diseaseMCCALL JOHN M·Filed 2011·Granted Dec 1, 2015·11 cites·48 claims
- 0988US11833159B2Non-hormonal steroid modulators of NF-kB for treatment of diseaseREVERAGEN BIOPHARMA INC·Filed 2020·Granted Dec 5, 2023·1 cites·12 claims
- 1088US8673887B2Non-hormonal steroid modulators of NF-kB for treatment of diseaseVALIDUS GENETICS·Filed 2012·Granted Mar 18, 2014·10 cites·4 claims
- 1187US2024285650A1NON-HORMONAL STEROID MODULATORS OF NF-kB FOR TREATMENT OF DISEASEREVERAGEN BIOPHARMA INC·Filed 2023·Application pending·0 cites
- 1286US11690853B2Non-hormonal steroid modulators of NF-κβ for treatment of diseaseREVERAGEN BIOPHARMA INC·Filed 2020·Granted Jul 4, 2023·1 cites·13 claims
- 1378US2024307411A1Non-hormonal steroid modulators of nf-kappa beta for treatment of diseaseREVERAGEN BIOPHARMA INC·Filed 2023·Application pending·0 cites
- 1474US2020148717A1Non-hormonal steroid modulators of nf-kappa beta for treatment of diseaseREVERAGEN BIOPHARMA INC·Filed 2019·Application pending·0 cites
- 1571US2022324902A1Non-hormonal steroid modulators of nf-kappa beta for treatment of diseaseREVERAGEN BIOPHARMA INC·Filed 2021·Application pending·0 cites
- 1669US2025145657A1Non-hormonal steroid modulators of nf-kappa beta for treatment of diseaseREVERAGEN BIOPHARMA INC·Filed 2025·Application pending·0 cites
- 1753US10000525B2Non-hormonal steroid modulators of NF-κB for treatment of diseaseREVERAGEN BIOPHARMA INC·Filed 2015·Granted Jun 19, 2018·0 cites·18 claims
Join the waitlist — get patent alerts
Get an alert when Kanneboyina Nagaraju files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →